Advanced Biomed (ADVB) Cash from Investing Activities (2024 - 2026)
Advanced Biomed (ADVB) posted Cash from Investing Activities of -$1264.0 for Q1 2026, up 90.21% sequentially from -$12906.0 in Q4 2025, and up 42.93% YoY from -$884.32 in Q1 2025.
Advanced Biomed (ADVB) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Advanced Biomed (ADVB) has 3 years of Cash from Investing Activities data on file, last reported at -$1264.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 42.93% year-over-year to -$1264.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36090.0 (up 44.27% YoY) and the FY2025 annual result came in at -$31650.0, up 57.29% from the prior year.
- Cash from Investing Activities climbed to -$1264.0 in Q1 2026 per ADVB's latest filing, from -$12906.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $26699.0 in Q1 2024, with the low at -$53256.0 in Q2 2024.
- Average Cash from Investing Activities over 3 years is -$8238.7, with a median of -$2215.0 recorded in 2025.
- The widest YoY moves for Cash from Investing Activities: up 91.14% in 2025, down 220.71% in 2025.
- Advanced Biomed's Cash from Investing Activities stood at $10692.0 in 2024, then tumbled by 220.71% to -$12906.0 in 2025, then soared by 90.21% to -$1264.0 in 2026.
- Business Quant data shows ADVB's Cash from Investing Activities at -$1264.0 in Q1 2026, -$12906.0 in Q4 2025, and -$1771.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Advanced Biomed | 6.22 Mn | 6.22 Mn | - | -1,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,264.00 |
| Mar 31, 2026 | -1,264.00 |
| Dec 31, 2025 | -12,906.00 |
| Dec 31, 2025 | -12,906.00 |
| Sep 30, 2025 | -1,771.00 |
| Sep 30, 2025 | -1,771.00 |
| Jun 30, 2025 | -20,149.00 |
| Jun 30, 2025 | -20,149.00 |
| Mar 31, 2025 | -2,215.00 |
| Mar 31, 2025 | -2,215.00 |
| Dec 31, 2024 | 10,692.00 |
| Dec 31, 2024 | 10,692.00 |
| Sep 30, 2024 | -19,978.00 |
| Sep 30, 2024 | -19,978.00 |
| Jun 30, 2024 | -53,256.00 |
| Jun 30, 2024 | -53,256.00 |
| Mar 31, 2024 | 26,699.00 |
| Mar 31, 2024 | 26,699.00 |